Catalyst Wire Dossier Catalyst Wire Dossier

Family-matched cytotoxic T lymphocytes (CTLs) therapy

adoptive cytotoxic T lymphocyte therapy · New York Medical College
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Family-matched cytotoxic T lymphocytes (CTLs) therapy, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone [Phase 3]

See pricing